| 000 | 01208 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250512005744.0 | ||
| 264 | 0 | _c19890828 | |
| 008 | 198908s 0 0 eng d | ||
| 022 | _a0901-9928 | ||
| 024 | 7 |
_a10.1111/j.1600-0773.1989.tb00595.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTuomainen, P | |
| 245 | 0 | 0 |
_aA methodological comparison of two formulations of temazepam in pharmacokinetic and pharmacodynamic aspects. _h[electronic resource] |
| 260 |
_bPharmacology & toxicology _cJan 1989 |
||
| 300 |
_a28-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGelatin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNervous System _xdrug effects |
| 650 | 0 | 4 | _aReaction Time |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 |
_aTask Performance and Analysis _xdrug effects |
| 650 | 0 | 4 |
_aTemazepam _xblood |
| 773 | 0 |
_tPharmacology & toxicology _gvol. 64 _gno. 1 _gp. 28-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0773.1989.tb00595.x _zAvailable from publisher's website |
| 999 |
_c2575133 _d2575133 |
||